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ﬁnal rule under the Clean Air Act (CAA) requiring new health effects
information and testing for motor vehicle fuels and fuel additives.
The rule, referred to as the ‘‘211(b)’’ rule, directed producers of
motor vehicle fuels and fuel additives to provide information on
the composition of emissions from their products and the potential
effects of these emissions on the public health andwelfare. To fulﬁll
these requirements, the American Petroleum Institute (API) orga-
nized the 211(b) Research Group, an unincorporated group of over
two hundred fuel, oxygenate, and fuel additive manufacturers,
which embarked upon a nearly 20 year effort to fulﬁll the require-
ments of the rule.
This issue of Regulatory Toxicology and Pharmacology is
devoted to describing the 211(b) rule requirements, the petroleum
industry’s response, and the results of toxicity studies on evapora-
tive emissions. This was by no means the ﬁrst effort to characterize
the hazards of gasoline. The ﬁrst article in the supplement
‘‘Gasoline Toxicology: Overview of Regulatory and Product
Stewardship Programs’’ (Swick et al., 2014a) describes other
mandatory and voluntary product stewardship and toxicology
testing programs that have generated hazard characterization data
for gasoline, the reﬁnery process streams used to blend gasoline,
and some of the individual chemical constituents of gasoline.
A major challenge was how to safely and correctly produce
samples of the individual substances to be tested. The second
paper in this issue ‘‘Health Assessment of Gasoline and Fuel
Oxygenate Vapors: Generation and Characterization of Test
Materials’’ (Henley et al., 2014) describes the extensive research
involved in designing a method to generate the evaporative
emissions used in these toxicology studies. Due to the extreme ﬂam-
mability of gasoline, it was not a trivial effort to develop and main-
tain safe handling procedures at several contract laboratories to
ship, store and perform studies with the test articles. The 211(b)
Rule required the construction of specialized equipment at each lab-
oratory, operated under strict conditions of temperature and evapo-
rated volume. Those conditions imposed signiﬁcant logistical and
safety issues which led the Research Group to undertake develop-
ment of an improved method for the generation of test substances.
The paper provides details of the fuels evaluated in the testing
program, and of the generation and characterization of the test
materials designed to mimic real-world human exposures. It also
describes GLP-compliant analytic procedures developed to monitor
atmospheric exposures in the animal studies and to ensure
reproducible exposures at multiple contract laboratories.
The following papers in this issue summarize and compare the
results of the toxicology studies on the evaporative emission
substances. These studies assessed whether oxygenates added togasoline inﬂuences potential hazard of the evaporative emissions
to which humans may be exposed. All of these studies conformed
to EPA guidelines where available, and where none existed, the
Research Group worked with academic and government experts
to develop sound experimental approaches to meet or exceed the
requirements of the 211(b) rule. This series of studies ‘‘Health
Assessment of Gasoline and Fuel Oxygenate Vapors’’ includes
the following:
Sub-chronic Inhalation Toxicity (Clark et al., 2014) relates the
results in Sprague–Dawley rats of seven separate inhalation
studies of baseline gasoline vapor condensate or vapor conden-
sate from gasoline blended with different oxygenates. These
studies also served as the main exposure studies for three sep-
arate satellite groups assessing genetic toxicity, neurotoxicity,
and immunotoxicity. Their conclusions are described in the fol-
lowing three papers:
Micronucleus and Sister Chromatid Exchange Evaluations – used
the bone marrow micronucleus test to identify chromosome
damage and aneuploidy, and the sister chromatid exchange
test (SCE) to detect reciprocal exchanges of DNA between
homologous loci of two sister chromatid strands of a duplicating
chromosome (Schreiner et al., 2014).
Neurotoxicity Evaluation – used standard neurotoxicity
screening batteries as well as analysis of glial ﬁbrillary acidic
protein (GFAP) in the brain. The GFAP assay was performed in
Dr. O’Callaghan’s laboratory as no commercial laboratories were
sufﬁciently experienced to perform this assay. The results
demonstrated that the GFAP assay is probably not effective
for evaluating petroleum hydrocarbon materials. (O’Callaghan
et al., 2014).
Immunotoxicity Evaluation – used antibody-forming cell (AFC)
response to the T-dependent antigen, sheep erythrocyte (sRBC)
to determine the effects on the humoral components of the
immune system (White et al., 2014).
Following those articles are the results of three studies which
investigated the reproductive and developmental toxicity of the
same gasoline and gasoline/oxygenate vapor condensates used in
the sub-chronic toxicity studies:
Reproductive Toxicity – used a two generation protocol design in
Sprague Dawley rats and also used the GFAP assay to assess
neurotoxicity (Gray et al., 2014).
Developmental Toxicity in Mice – evaluated the maternal and
developmental toxicity in CD-1 mice of both gasoline and
gasoline blended with MTBE (Roberts et al., 2014a).
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developmental toxicity in Sprague–Dawley rats of gasoline
and gasoline blended with six different oxygenates (Roberts
et al., 2014b).
Other novel aspects of the testing program included the use of
external experts to provide peer review of the laboratory reports.
Special thanks are owed to Drs. Richard Schlesinger, Thomas
Goldsworthy, and James Bond for their review and guidance. The
Research Group also contracted with independent quality assur-
ance experts to audit both the laboratories and the study reports
in addition to the QA procedures of the laboratory.
As to the future of gasoline toxicology and regulation, the
Research Group has completed all of the hazard screening studies
required in the 211(b) rule which demonstrate a low potential for
hazard from evaporative emissions encountered by the public
when refueling vehicles. Exposure assessment studies separately
conducted and reported as part of compliance with the 211(b) rule
(Zielinska et al., 2012), demonstrate a wide margin of safety
between various high-end exposure scenarios and the no observed
adverse effect levels (NOAEL) demonstrated in the hazard screen-
ing studies reported in this issue. In addition, post-1994 fuel and
vehicle regulations have continued to decrease exposure to
gasoline vapor and exhaust emissions (e.g. reduced vapor pressure,
sulfur, and benzene in the fuel; on-board refueling vapor canisters
in cars; strict speciﬁcations on portable gas cans; more stringent
tailpipe emission standards, etc.). The ﬁnal article in this issue,
‘‘Gasoline Risk Management: A Compendium of Regulations,
Standards, and Industry Practices’’ (Swick et al., 2014b), summa-
rizes those regulations which provide the U.S. federal government
extensive authority to regulate the entire gasoline lifecycle—from
manufacture, through distribution, to end-use—all of which are
subject to detailed, complex, and overlapping regulatory schemes
intended to protect human health, welfare, and the environment.
The article also describes the broad array of voluntary standards
and best management practices implemented by industry to
ensure that risks from gasoline manufacturing, distribution, and
use are minimized.
For those interested in additional detail on the 211(b) rule, the
appendix to this supplement, ‘‘Alternative Tier 2 Health Effects
Testing Requirements for Gasoline and Oxygenated Gasolines’’
describes the events and expert analyses leading up to thedevelopment of the rule, the tiered structure of the requirements,
what speciﬁc testing was required, and the overall objectives of
the program. Also discussed, are the publication of the proposed
rule and the subsequent public comment period, and the changes
made to the ﬁnal rule in acknowledgment of already existing data
and laboratory safety concerns.References
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